The Biotech Market Is Raining Gold Smaller biotech firms have hit huge paydays in 2018 as larger companies continue to add these firms' drugs to their own pipelines, expanding their clinical assets. Global acquisitions of biotech companies are expected to be at the highest annual level in 12 years, according to Bloomberg data. Follow Warren Buffet's simple advice: | "Opportunities come infrequently. When it rains gold, put out the bucket, not the thimble." | | |
Aucun commentaire:
Enregistrer un commentaire